Stryker (SYK) Stock May Trade At A Discount Despite FDA Clearance

Stryker has had a mixed run, with the share price up 22.3% over three years but still showing declines over the past year. This puts fresh focus on whether the current US$307.08 level lines up with the cash the business can generate. With new products, fresh partnerships and legal scrutiny all in play, the question for anyone looking at the stock is how those moving parts feed into its underlying cash flow story. The 22.3% gain over three years means a holder today is looking at a stock...